Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PULSE BIOSCIENCES, INC. Director's Dealing 2025

Sep 13, 2025

32093_dirs_2025-09-12_96573ab4-3492-4c69-8b10-66c41120b6a6.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PULSE BIOSCIENCES, INC. (PLSE)
CIK: 0001625101
Period of Report: 2025-09-10

Reporting Person: DUGGAN ROBERT W (Director, 10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-09-10 Common Stock P 34659 $14.66 Acquired 47551200 Direct
2024-09-11 Common Stock P 12800 $14.77 Acquired 47564000 Direct
2024-09-12 Common Stock P 145140 $14.41 Acquired 47709140 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 630109 Indirect
Common Stock 450189 Indirect

Footnotes

F1: Volume-weighted average price. The price per share actually paid by the Reporting Person ranged from $14.51 to $14.81 per share. For all transactions reported in this Form 4 using a weighted average price, the Reporting Person undertakes upon request by the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased at each separate price within the range.

F2: Volume-weighted average price. The price per share actually paid by the Reporting Person ranged from $14.57 to $14.79 per share.

F3: Volume-weighted average price. The price per share actually paid by the Reporting Person ranged from $13.90 to $14.75 per share.

F4: Shares are held by Genius 24C Inc., of which the Reporting Person is the sole shareholder.

F5: Shares are held by Blazon Corporation, of which the Reporting Person is the sole shareholder.